The Global Prevalence of Infections in Urology Study: A Long-Term, Worldwide Surveillance Study on Urological Infections

Pathogens
Florian M E WagenlehnerTruls E Bjerklund Johansen

Abstract

The Global Prevalence of Infections in Urology (GPIU) study is a worldwide-performed point prevalence study intended to create surveillance data on antibiotic resistance, type of urogenital infections, risk factors and data on antibiotic consumption, specifically in patients at urological departments with healthcare-associated urogenital infections (HAUTI). Investigators registered data through a web-based application (http://gpiu.esiu.org/). Data collection includes the practice and characteristics of the hospital and urology ward. On a certain day in November, each year, all urological patients present in the urological department at 8:00 a.m. are screened for HAUTI encompassing their full hospital course from admission to discharge. Apart from the GPIU main study, several side studies are taking place, dealing with transurethral resection of the prostate, prostate biopsy, as well as urosepsis. The GPIU study has been annually performed since 2003. Eight-hundred fifty-six urology units from 70 countries have participated so far, including 27,542 patients. A proxy for antibiotic consumption is reflected by the application rates used for antibiotic prophylaxis for urological interventions. Resistance rates of most uropathogens ...Continue Reading

Associated Clinical Trials

Sep 11, 2018·Florian M E Wagenlehner

References

Mar 24, 2004·International Journal of Antimicrobial Agents·Truls E Bjerklund Johansen
Jul 11, 2006·International Journal of Antimicrobial Agents·Truls E Bjerklund JohansenUNKNOWN Board of the European Society of Infections in Urology
Oct 20, 2006·European Urology·Truls E Bjerklund JohansenUNKNOWN European Society of Infections in Urology
Oct 4, 2012·European Urology·Mete ÇekUNKNOWN Global Prevalence Study of Infections in Urology Investigators
Mar 29, 2014·The New England Journal of Medicine·Shelley S MagillUNKNOWN Emerging Infections Program Healthcare-Associated Infections and Antimicrobial Use Prevalence Survey Team

❮ Previous
Next ❯

Citations

Jun 22, 2016·MMW Fortschritte der Medizin·Johannes BognerUlrich Seybold
Nov 20, 2016·Current Opinion in Urology·Magnus J Grabe, Karl-Johan Lundström
Jul 18, 2020·Scandinavian Journal of Urology·William DugganBen Challacombe
Jul 15, 2020·Nature Reviews. Urology·Livia Lacerda Mariano, Molly A Ingersoll
Aug 23, 2018·Neurourology and Urodynamics·Marcio A AverbeckLinda Cardozo
Dec 5, 2019·Nature Reviews. Urology·Kurt G Naber, Florian M E Wagenlehner
Aug 28, 2020·Nature Reviews. Urology·Florian M E WagenlehnerZafer Tandogdu
Oct 30, 2019·Der Urologe. Ausg. A·M Roschkow
May 7, 2019·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Meera TandanSheryl Zimmerman
Oct 8, 2020·Der Urologe. Ausg. A·J KranzL Schneidewind
Sep 4, 2020·Current Opinion in Urology·Ekaterina Kulchavenya
Apr 21, 2021·Medizinische Klinik, Intensivmedizin und Notfallmedizin·Jennifer KranzLaila Schneidewind
Jan 16, 2020·Urologia Internationalis·Hulya CaskurluTurhan Caskurlu

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Software Mentioned

Access
MySQL

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.